IL1B and metabolic dysfunction-associated steatohepatitis: MiR-let-7c-5p upregulates the IL1B gene in NASH patients, and it has been shown that an increase in IL-1β production leads to the activation of fibrogenic responses in HSCs, including inflammation and secretion of tissue inhibitor of metalloproteinase-1 [131].